Streetbeat News

Earnings

INDV

Indivior (NASDAQ:INDV), a pharmaceutical company specializing in treatments for substance use disorders and mental illnesses, reported a 12% year-over-year revenue growth for Q1, reaching $284 million. The growth was primarily driven by sales of SUBLOCADE, a treatment for opioid use disorder. Despite facing challenges such as Medicaid disenrollments, a cyberattack, and trade destocking, the company remains optimistic, reconfirming its 2024 guidance for SUBLOCADE revenue and margin expansion. Net income and operating profit also saw increases compared to the same period last year.

Portfolio Pulse from Nina Zdinjak

April 25, 2024 | 2:04 pm

TECK

Teck Resources shares are trading lower following a Q1 earnings miss, indicating a negative market reaction to the financial performance.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 2:04 pm

AOS

A.O. Smith's shares dropped following mixed Q1 results and a reaffirmation of its FY24 guidance, which fell short of expectations.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 2:03 pm

RJF

Raymond James Financial shares are trading lower following the announcement of mixed Q2 financial results, indicating a disparity between expected and actual financial performance.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 2:01 pm

RS

Reliance Steel & Aluminum's shares dropped following the announcement of Q1 financial results that did not meet expectations.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 1:59 pm

CHKP

EIS

ISRA

Check Point Software Technologies Ltd (CHKP) reported a 6% year-on-year revenue growth for Q1 2024, reaching $598.80 million and surpassing consensus estimates. Adjusted EPS was $2.04, beating the consensus of $2.01. However, revenue from products and licenses fell by 7.1%. The company introduced new security technologies but saw a decrease in operating margin and operating cash flow. CHKP stock declined by 3.58% following the announcement. Investors can also gain exposure to CHKP through IShares MSCI Israel ETF (EIS) and VanEck Israel ETF (ISRA).

Portfolio Pulse from Anusuya Lahiri

April 25, 2024 | 1:58 pm

TCNNF

TLRY

Recent analysis by Viridian Capital Advisors highlights significant differences in year-to-date performance between U.S. multi-state operators (MSOs) and Canadian licensed producers (LPs) in the cannabis sector. U.S. MSOs have seen an average return of 26.4%, while Canadian LPs have a modest 1.3%. However, excluding outliers like Trulieve Cannabis (TCNNF) and Tilray Brands (TLRY), the performance gap narrows significantly. The market's irrational behavior, influenced by regulatory changes and speculation, has led to volatility. Tilray faces challenges despite revenue gains, with a significant stock price drop after revising its financial outlook. Conversely, Trulieve's strategic success and market growth, especially with Germany's legalization and potential in Florida, position it for significant valuation increases.

Portfolio Pulse from Nicolás Jose Rodriguez

April 25, 2024 | 1:57 pm

TRU

TransUnion shares are trading higher following the announcement of better-than-expected Q1 financial results and positive guidance for Q2.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 1:56 pm

TYL

Tyler Technologies' shares surged following the announcement of Q1 earnings and sales surpassing expectations, along with positive guidance for FY24.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 1:55 pm

BCS

DB

META

Earnings reports from Deutsche Bank, Barclays, and Neste failed to impress, leading to negative stock movements. BHP Group's takeover bid for Anglo American boosted its share price significantly. Meta's earnings exceeded expectations but concerns over its metaverse investments led to a significant market cap loss. US GDP data and its implications for Fed policy, along with the Dow Jones' performance, are key focuses for investors.

Portfolio Pulse from Naeem Aslam

April 25, 2024 | 1:52 pm